Patrick Lee Green, PhD
Academic Title: Professor and Associate Dean
Research Program: Leukemia and Hematologic Malignancies
Columbus, Ohio 43210-1006
About Me
More info forI am a professor and associate dean for research and graduate studies in the College of Veterinary Medicine at The Ohio State University, where I also direct the Center for Retrovirus Research. I am the associate director for basic sciences at the OSUCCC – James and a member of the Leukemia and Hematologic Malignancies Program.
My research focuses on understanding the molecular basis of T-lymphocyte transformation, as well as the induction of leukemia/lymphoma and neurological diseases by the human T-cell leukemia viruses (HTLVs). My lab investigates viral and cellular regulators of HTLV gene expression/replication, cellular transformation and virus survival or persistence in infected hosts.
Recent work has revealed the importance of a viral gene, termed Hbz, in the maintenance and proliferation of HTLV-1 infected cells. In fact, Hbz is the only viral gene consistently expressed in HTLV-1 associated adult T cell leukemia/lymphoma. Hbz and the cellular pathways it impacts will be important targets for treatment and prevention of HTLV-1-associated diseases.
I have authored or co-authored many articles in well-regarded publications, including Viruses, Journal of Virology, Blood, Retroviology and Cancer Cell.
Research Interests
More info for- Human T-Lymphotropic Virus 1
- Leukemia-Lymphoma, Adult T-Cell
Academic Office & Contact Information
More info forAcademic Office:
Veterinary Medicine Academic
1900 Coffey Rd
Columbus, Ohio 43210-1006Phone:
614-688-4899Email:
green.466@osu.eduPublications
More info forMarch 26, 2024Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
Shichijo T, Yasunaga JI, Sato K, Nosaka K, Toyoda K, Watanabe M, Zhang W, Koyanagi Y, Murphy EL, Bruhn RL, Koh KR, Akari H, Ikeda T, Harris RS, Green PL, Matsuoka M
Proc Natl Acad Sci U S A
January 9, 2024An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits.
Tu JJ, King E, Maksimova V, Smith S, Macias R, Cheng X, Vegesna T, Yu L, Ratner L, Green PL, Niewiesk S, Richner JM, Panfil AR
J Virol
June 1, 2023HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development.
Maksimova V, Wilkie T, Smith S, Phelps C, Melvin C, Yu L, Niewiesk S, Green PL, Panfil AR
PLoS Pathog
January 14, 2022Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T cell leukemia/lymphoma.
Daenthanasanmak A, Bamford RN, Yoshioka M, Yang SM, Homan PJ, Karim B, Bryant BR, Petrus MN, Thomas C, Green PL, Miljkovic MD, Conlon KC, Waldmann TA
Blood Adv
November 24, 2021Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in Adult T-cell leukemia/lymphoma.
Ishio T, Kumar S, Shimono J, Daenthanasanmak A, Dubois S, Lin Y, Bryant BR, Petrus MN, Bachy E, Huang DW, Yang Y, Green PL, Hasegawa H, Maeda M, Goto H, Endo T, Yokota T, Hatanaka KC, Hatanaka Y, Tanaka S, Matsuno Y, Yang Y, Hashino S, Teshima T, Waldmann TA, Staudt LM, Nakagawa M
Blood
May 21, 2021Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF.
Cheng X, Joseph A, Castro V, Chen-Liaw A, Skidmore Z, Payton JE, Ratner L, Edwards JR, Ueno T, Fujisawa JI, Rauch DA, Challen GA, Martinez MP, Green P, Griffith M
PLoS Pathog